GALT
Galectin Therapeutics Inc.stockNASDAQ
Market OpenNov 19, 2026 3:12:25 PM EST
2.88USD-3.356%(-0.10)102,572
GALT Financials
In Q3 FY 2026 (ended ), Galectin Therapeutics Inc. (GALT) reported net income of −$3.53M, operating cash flow of −$2.27M, and assets of $13.01M (filed ).
Loading financial flows…
